Selvom dette ikke er dokumenteret for Irbesartan Krka, kan der forventes en lignende effekt med angiotensin- II receptorantagonister.
While this is not documented with Irbesartan Krka, a similar effect should be anticipated with angiotensin-II receptor antagonists.